| Literature DB >> 29566320 |
Paul J Feldblum1, Chikondi Mwambula2, Monija Selemani2, Sarah Long1, Dyson James Telela3, Elled Mwenyekonde3, Jaim Jou Lai1, Valentine Veena4, Phyela Mbeya2.
Abstract
We evaluated the safety and acceptability of the ShangRing device for male circumcision during routine clinical service delivery in Namitete, Malawi. We conducted a prospective observational study enrolling 500 HIV-negative men ages 18 to 49 years at St. Gabriel's Hospital. Participants returned for two follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement). We assessed pain, adverse events (AEs), acceptability, and healing. 500 men were screened; 498 were circumcised using the ShangRing and comprised the analysis population. Seven participants (1.4%) experienced moderate AEs related to circumcision. 93% were judged to be completely healed at or before the day 42 visit; 6% were judged to be healed later than the day 42 visit; 5 participants (1.0%) were lost to follow-up. 98% of men stated they were very satisfied with the appearance of their circumcised penis, and 99.6% would recommend ShangRing circumcision to family/friends. Adult male circumcision using the ShangRing was safe with a low AE rate at this service delivery site. Acceptability factors were also favorable. Addition of the ShangRing device could be beneficial to achieving the goals of the circumcision program in Malawi.Entities:
Keywords: Malawi; ShangRing device; male circumcision; safety
Mesh:
Year: 2016 PMID: 29566320 DOI: 10.29063/ajrh2016/v20i4.6
Source DB: PubMed Journal: Afr J Reprod Health ISSN: 1118-4841